Regulatory Status

The plant has been designed, built and qualified to comply with the global regulations and was initially inspected by the United States Food and Drug Administration (USFDA) in 2008 with two minor non-cGMP related observations. The plant was re-inspected in 2013 in a response to several product launches and additional ANDA submissions with no 483 observations. Additionally the facilities have been inspected successfully twice by the China Food and Drug Administration (CFDA) since our inception.
Quality Systems
Our Novast teams are multinational groups of experienced professionals from countries including the China, United States, Canada and India. More...
Web Design and Development in Hyderabad
Strategy
Novast's business model utilizes our extensive expertise, experience and proven ability in product research & development and manufacturing. More...
Business Solutions Provider
Our Investors
We are supported by the following global investors

More...
Business Solutions